KIMBERLY SMITH: Open Payments
NPI 1134593601 · POWELL, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 43 payments from 12 companies in 2025. Trend: 2023 $49 · 2024 $313 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $188 |
| Novo Nordisk Inc | 6 | $124 |
| AstraZeneca Pharmaceuticals LP | 6 | $96 |
| Lilly USA, LLC | 4 | $69 |
| PFIZER INC. | 2 | $44 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| Corcept Therapeutics | 2 | $38 |
| MIMEDX Group, Inc. | 1 | $37 |
| Alexion Pharmaceuticals, Inc. | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: VRAYLAR, AIRSUPRA, Ozempic, MOUNJARO, Wegovy, PREVNAR 20, Jornay PM, Korlym.
Industry payments across OH — which companies pay providers there.
